当前位置:首页 - 行情中心 - 和元生物(688238) - 财务分析 - 现金流量表

和元生物

(688238)

  

流通市值:44.37亿  总市值:44.91亿
流通股本:6.41亿   总股本:6.49亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金184,194,824.98107,711,534.4942,360,963.7241,887,804.09
  收到的税费返还---86,538,182.74
  收到其他与经营活动有关的现金8,754,656.156,092,665.152,729,681.8942,181,986.37
  经营活动现金流入小计192,949,481.13113,804,199.6445,090,645.59370,607,973.2
  购买商品、接受劳务支付的现金111,382,774.0874,993,780.6540,242,328.54146,412,837.34
  支付给职工以及为职工支付的现金145,674,984.8997,783,019.3451,358,995.5208,389,699.34
  支付的各项税费8,167,745.625,524,246.522,310,337.776,772,710.34
  支付其他与经营活动有关的现金38,304,791.9324,002,770.7212,592,665.3370,101,204.48
  经营活动现金流出小计303,530,296.52202,303,817.23106,504,327.14431,676,451.5
  经营活动产生的现金流量净额-110,580,815.39-88,499,617.59-61,413,681.55-61,068,478.3
二、投资活动产生的现金流量:
  收回投资收到的现金223,685,358.8207,783,792.1490,000,000160,000,000
  取得投资收益收到的现金1,083,401.26680,175.51527,816.32824,149.85
  处置固定资产、无形资产和其他长期资产收回的现金净额1,201,0001,201,00053,0002,670
  收到的其他与投资活动有关的现金34,604,082.48--18,600,000
  投资活动现金流入小计260,573,842.54209,664,967.6590,580,816.32179,426,819.85
  购建固定资产、无形资产和其他长期资产支付的现金104,909,985.590,939,935.7271,235,980.13167,457,233.05
  投资支付的现金265,000,000200,000,00080,000,000190,000,000
  取得子公司及其他营业单位支付的现金116,922.06116,922.06-283,077.94-
  支付其他与投资活动有关的现金21,221,013.74--31,000,000
  投资活动现金流出小计391,247,921.3291,056,857.78150,952,902.19388,457,233.05
  投资活动产生的现金流量净额-130,674,078.76-81,391,890.13-60,372,085.87-209,030,413.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金---3,704,316
  取得借款收到的现金234,903,753.27200,000,000180,000,00090,000,000
  筹资活动现金流入小计234,903,753.27200,000,000180,000,00093,704,316
  偿还债务支付的现金86,200,50078,717,00077,483,50031,184,000
  分配股利、利润或偿付利息支付的现金5,907,487.573,713,506.141,643,863.136,374,929.09
  支付其他与筹资活动有关的现金101,739,001.89100,137,977.1658,488,697.353,936,368.18
  筹资活动现金流出小计193,846,989.46182,568,483.3137,616,060.4841,495,297.27
  筹资活动产生的现金流量净额41,056,763.8117,431,516.742,383,939.5252,209,018.73
四、汇率变动对现金及现金等价物的影响-66,210.72-23,479.12-5,811.58-202,675.37
五、现金及现金等价物净增加额-200,264,341.06-152,483,470.14-79,407,639.48-218,092,548.14
  加:期初现金及现金等价物余额434,894,251.83434,894,251.83434,894,251.83652,986,799.97
  期末现金及现金等价物余额234,629,910.77282,410,781.69355,486,612.35434,894,251.83
补充资料:
  净利润--104,481,169.78--322,182,350.33
  资产减值准备-509,253.14-55,507,906.49
  固定资产和投资性房地产折旧-45,066,475-78,592,321.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-45,066,475-78,592,321.65
  无形资产摊销-1,013,491.86-1,967,244.35
  长期待摊费用摊销-1,360,266.78-6,748,124.79
  处置固定资产、无形资产和其他长期资产的损失-879,106.69--5,900,892.14
  公允价值变动损失--84,032.41--259,112.69
  财务费用-3,735,988.14-7,657,469.67
  投资损失-306,068.54--3,577.44
  递延所得税-1,636,905.43-13,263,529.11
  其中:递延所得税资产减少-1,667,041.85-18,070,454.15
    递延所得税负债增加--30,136.42--4,806,925.04
  存货的减少--3,677,137.3--2,002,935.57
  经营性应收项目的减少--20,158,514.13-42,545,097.56
  经营性应付项目的增加--15,834,876.89-54,754,787.03
  其他---4,021,097.27
  现金的期末余额-282,410,781.69-434,894,251.83
  减:现金的期初余额-434,894,251.83-652,986,799.97
  现金及现金等价物的净增加额--152,483,470.14--218,092,548.14
公告日期2025-10-282025-08-192025-04-242025-04-18
审计意见(境内)标准无保留意见
TOP↑